16 May 2019
The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.
21 March 2019
Researchers in our Sleep and Circadian Neuroscience Institute are working with Havant & South Downs College on a teenage sleep study.
19 February 2019
Researchers in Oxford have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK’s most common cause of sight loss.
8 October 2018
The positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in this week’s edition of Nature Medicine.
30 September 2018
Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.
12 March 2018
Researchers at the Sleep and Circadian Neuroscience Institute (SCNi) have been working with visual artist Martin Kohout to reveal the stories of the night-shift workers who keep London running.
3 October 2017
In a laboratory study in Oxford, researchers have shown how it might be possible to reverse blindness using gene therapy to reprogram cells at the back of the eye to become light sensitive.
3 January 2017
Circadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
10 November 2016
The trial involves injecting a virus into the eye to deliver billions of healthy genes to replace a key missing gene for choroideremia sufferers.
9 August 2016
A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
29 April 2016
Pioneering gene therapy has restored some vision to John Radcliffe Hospital patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.
31 March 2016
Experts call for introduction of sleep guidelines in new report